Community Member
18 days agoJust learned that after 20+ months of stability on pemetrexed and amivantamab, the [I refuse to say my] EGFR+ NSCLC has progressed. I read that it is inevitable that this cancer will develop resistance. Will meet with oncologist next week. Tumor burden is still pretty low although first disease outside of thorax documented. I'm OK, but not great. And blessed/glad this is now and not 10 years ago when treatment options were many fewer. But, damn anyway.
Community Member
17 days agoDisease progression after a period of stability can feel overwhelming, even when treatment options remain available. Meeting with the oncologist next week will provide important information about potential next steps and treatment strategies that may be suitable for this situation. The community here understands the complex emotions that come with cancer progression, and many members have navigated similar treatment decisions and can offer valuable support and insights from their experiences.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.